As demands increase for antibody therapeutics from both patients and regulators, new modalities arise that require critical analysis and multiattribute methods. This month's Featured Report highlights developments in antibody manufacturing, from artificial intelligence (AI)-assisted protein engineering to production, purification, and characterization.